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Abstract
Background: Recent evidence suggests that oxytocin (OT), secreted in the superficial spinal cord
dorsal horn by descending axons of paraventricular hypothalamic nucleus (PVN) neurons, produces
antinociception and analgesia. The spinal mechanism of OT is, however, still unclear and requires
further investigation. We have used patch clamp recording of lamina II neurons in spinal cord slices
and immunocytochemistry in order to identify PVN-activated neurons in the superficial layers of
the spinal cord and attempted to determine how this neuronal population may lead to OT-
mediated antinociception.
Results: We show that OT released during PVN stimulation specifically activates a subpopulation
of lamina II glutamatergic interneurons which are localized in the most superficial layers of the
dorsal horn of the spinal cord (lamina I-II). This OT-specific stimulation of glutamatergic neurons
allows the recruitment of all GABAergic interneurons in lamina II which produces a generalized
elevation of local inhibition, a phenomenon which might explain the reduction of incoming Aδ and
C primary afferent-mediated sensory messages.
Conclusion: Our results obtained in lamina II of the spinal cord provide the first clear evidence
of a specific local neuronal network that is activated by OT release to induce antinociception. This
OT-specific pathway might represent a novel and interesting therapeutic target for the
management of neuropathic and inflammatory pain.
Background
Oxytocin (OT) is a nonapeptide synthesized in magnocel-
lular neurons of the paraventricular and supraoptic nuclei
of the hypothalamus and acts as a neurohormone during
parturition and milk ejection reflex [1]. It is also synthe-
sized in parvocellular neurons of the paraventricular
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tral nervous system including the spinal cord. In the spi-
nal cord, oxytocinergic projection sites [2-5] match well
OT binding sites [6,7] in the superficial layers of the dorsal
horn and in the autonomic regions (intermediolateral
columns, intermediomedial grey matter, lamina X and
sacral parasympathetic nucleus). Using electron micros-
copy, OT-positive synaptic terminals were found to form
mainly axodendritic synapses on lamina I-II neurons [8].
Although some conflicting results have been reported in
the literature [9,10], analgesic effects of OT have been
reported in most studies after systemic and/or central
administration of OT in naive rodents [11] or during the
development of inflammatory [12-14] or neuropathic
pain [15]. An OT-sensitive antinociception can also be
induced in rats by massage-like stimulation [16,17], swim
stress [18] and electrical stimulation the PVN in naïve
[19,20] and neuropathic rats [21,22], suggesting the
involvement of an endogenous OT receptor-dependent
analgesic system.
Little is known about the possible mechanisms and neu-
ronal networks mediating these antinociceptive effects of
OT in the spinal cord. PVN stimulation or OT infusion
reduced the incoming peripheral Aδ and C-fiber activa-
tion in dorsal horn spinal neurons [21,23]. It should be
noted here that most of these in vivo results were obtained
from neurons receiving convergent sensory informations
(from Aβ, Aδ and C fibers) and recorded in deep layers
(Lamina III-V) of the dorsal horn. In some rare cases, neu-
rons were also shown to be excited after application of OT
[23] or after PVN stimulation [24]. However, in spinal
cord slices of rats and mice, OT reduced electrically-
evoked glutamatergic synaptic currents between primary
afferents and lamina II neurons [18] whereas in primary
cultures of neonatal laminae I-III dorsal horn neurons, OT
produced a facilitation of glutamatergic synaptic trans-
mission via a presynaptic mechanism of action [25].
Finally, OT was shown to inhibit glutamate-induced exci-
tation of spinal neurons in vivo [23], and, in a recent
study, antinociceptive action of spinal OT is proposed to
be mediated by a GABAergic mechanism [24].
In order to clarify the effects of OT in spinal antinocicep-
tion, we determined its effects on excitatory and inhibi-
tory synaptic transmission in lamina II, a layer containing
mainly local interneurons which are thought to play an
important role in spinal pain processing by controlling
the local balance between excitation and inhibition.
Using electrophysiological and morphological tools, we
characterized the effects of OT on lamina II neurons, iden-
tified a subpopulation of OT-sensitive postsynaptic target
neurons, specify their neurochemical identity and their
role in recruiting a local interneuronal network leading to
antinociception.
Results
Characterization of fast spontaneous synaptic 
transmission in lamina II interneurons
In all lamina II neurons recorded in the whole-cell config-
uration of the patch-clamp technique (n = 39), spontane-
ous inhibitory and excitatory postsynaptic currents
(sIPSCs and sEPSCs, respectively) were observed (Figure
1). Under our experimental conditions, the chloride equi-
librium potential was set at -60 mV, and IPSCs were
recorded as transient outward currents when lamina II
neurons were held at 0 mV (Figure 1A). Both glycine- and
GABAA receptor-mediated sIPSCs (GABAA-R sIPSCs) were
present and were blocked by 1 μM strychnine (not
shown) and 10 μM bicuculline respectively (Figure 1A).
We found that pharmacologically-isolated GABAA-R sIP-
SCs occurred at a mean frequency of 0.12 ± 0.02 Hz and
exhibited a mean amplitude of 11.1 ± 1.5 pA (n = 6). For
comparison, fast glutamatergic sEPSCs were detected as
transient inward currents at a holding potential of -60 mV
(Figure 1B). They occurred at a mean frequency of 1.26 ±
0.47 Hz and had a mean amplitude of -16.3 ± 0.8 pA (n =
16). These currents were blocked by 6-cyano-7-nitroqui-
noxaline-2,3-dione (CNQX, 10 μM) (Figure 1B), indicat-
ing that they were mediated by the AMPA subtype of
glutamate receptors. The detailed properties of the kinet-
ics of each type of current are given in Table 1 for sponta-
neous and miniature (i.e. recorded in the presence of 0.5
μM of TTX) synaptic events.
Consequences of oxytocin agonist application (TGOT) on 
spontaneous synaptic transmission recorded in lamina II 
neurons
Spontaneous AMPA-receptor-mediated EPSCs (AMPA-R
sEPSCs) were recorded in the presence of 1 μM strychnine
and 10 μM bicuculline (Figure 2A). Bath application of
the selective oxytocin receptor agonist (TGOT 1 μM)
increased the frequency of occurrence (but not the ampli-
tude) of spontaneous AMPA-R sEPSCs (Figure 2A, histo-
gram) in 5 out of 14 lamina II neurons (35.7%). This
frequency of sEPSCs was of 1.04 ± 0.38 Hz under control
conditions and increased to 1.79 ± 0.55 Hz in the pres-
ence of TGOT (n = 5). This change was reversible and
found to be statistically significant (p < 0.05) and repre-
sented an average increase of 103 ± 27%. By contrast to its
relatively modest effect on sEPSCs, TGOT (1 μM) induced
a significant increase in the amplitude (Control: 14.4 ±
1.8 pA; TGOT: 25.5 ± 2.6 pA, n = 6; p < 0.05) and fre-
quency of GABAA-R sIPSCs (Control: 0.12 ± 0.02 Hz;
TGOT: 1.69 ± 0.61 Hz, n = 6; p < 0.05) in all lamina II
neurons from which we recorded (n = 6 out of 6). The
effect of TGOT was fully reversible after 10–15 minutes of
washout and was never observed in the presence of OTAPage 2 of 12
(page number not for citation purposes)
Molecular Pain 2008, 4:19 http://www.molecularpain.com/content/4/1/19
Page 3 of 12
(page number not for citation purposes)
characterization of fast spontaneous inhibitory and excitatory synaptic currents in lamina IIFigure 1
characterization of fast spontaneous inhibitory and excitatory synaptic currents in lamina II. Glycine-receptor-
mediated sIPSCs were blocked in these experiments by adding 1 μM strychnine in the general bath perfusion. A: GABAA-
receptor-mediated sIPSCs (GABAA-R sIPSCs) were identified as outward currents (left panel) at a holding potential of 0 mV. 
These sIPSCs were reversibly blocked in the presence of 10 μM bicuculline, a selective antagonist of GABAA-Rs. Panel on the 
right illustrates an averaged current obtained from 46 individual traces. GABAA-R sIPSCs were best described by a monoexpo-
nential decay time constant in both the activation phase (τR = 1.3 ms) and deactivation phase (τD = 45.2 ms). B: At a holding 
potential of -60 mV (i.e. at the equilibrium potential for Cl- ions), only fast inward currents were detected (left panel). These 
events were AMPA-type glutamate-receptor-mediated sEPSCs (AMPA-R sEPSCs) since they were reversibly inhibited in the 
presence of CNQX (10 μM) a specific blocker of AMPA subtype glutamate receptor. The trace on the right was obtained by 
averaging 168 individual AMPA-R sEPSCs. These sEPSCs were characterized by a τR of 0.9 ms and τD of 4.1 ms).
Molecular Pain 2008, 4:19 http://www.molecularpain.com/content/4/1/19(d(CH2)5 - [Tyr(Me)2, Thr4-Tyr-NH29] ornithine vaso-
tocin, 1 μM), a selective OT receptor antagonists (n = 5,
not shown). This result indicated that the increase in fre-
quency of sIPSCs was mediated by the activation of OT
receptors.
Presynaptic OT receptors on glutamatergic synaptic 
terminals
In the presence of TTX (0.5 μM), TGOT also stimulated
the frequency of AMPA-R mEPSCs (Figure 2A, left panel
and histogram) in a subpopulation (50%, 6 out of 12) of
lamina II neurons. The mean frequency of mEPSCs
increased from 1.27 ± 0.30 Hz under control conditions
to 2.31 ± 0.65 Hz in the presence of TGOT (1 μM). This
change in frequency was statistically significant (p < 0.05)
and represented an average increase of +96.8 ± 31.0% (n
= 6; Figure 2A, right histogram) which was similar to that
observed for sEPSCs. In sharp contrast with this result,
TGOT failed to change the frequency of occurrence of
GABAA-R mIPSCs (Figure 2B, right histogram) since, in
all lamina II neurons recorded, the mean frequency
remained stable (Control: 0.13 ± 0.03 Hz; TGOT: 0.12 ±
0.04 Hz, n = 6; p > 0.05; average change: -1.2 ± 9.1%, n =
6). TGOT had no apparent effect on the frequency of gly-
cine receptor-mediated spontaneous and miniature syn-
aptic transmission (not shown).
TGOT reveals a novel population of AMPA-R mEPSCs 
having slow rise and decay kinetics
Detailed analysis of mEPSC kinetics revealed that in the
presence of TGOT a subpopulation of mEPSCs remained
unchanged whereas an additional population of mEPSCs
seemed to appear. As illustrated in Figure 3B–C, this
"novel" population of miniature AMPA-R EPSCs had
larger time to peak values (τR: +20.9 ± 4.6%, n = 6, p <
0.01), slower deactivation time constants (τD: +52.7 ±
7.9%; n = 6, p < 0.001) and smaller mean amplitudes
(Amp.: -20.9 ± 2.0%; n = 6, p < 0.001). The effect of TGOT
became particularly clear when the distribution of the
monoexponential decay time constants of AMPA-R mEP-
SCs was represented under the form of a binned histo-
gram (Figure 3A). Under control conditions (Figure 3A,
top histogram), the distribution of the decay time con-
stants could be adjusted by a Gaussian distribution cen-
tered at 3.21 ms, while in the presence of TGOT this
distribution was strongly asymmetric because of the pres-
ence of the "newly" detected mEPSCs with slow decay
time constants (Figure 3A, bottom histogram). These
TGOT-sensitive mEPSCs were fully blocked by CNQX (10
μM) and disappeared upon washout of TGOT.
These results suggest that presynaptic OT receptors facili-
tate glutamatergic synaptic transmission by revealing a
novel or previously silent or undetected population of
EPSCs.
Immunohistochemical identification of PVN-activated 
(OT-sensitive) dorsal horn neurons
In order to localize and to tentatively identify the pheno-
type of the lamina II neurons activated upon OT release,
we used an immunohistochemical approach based on c-
Fos nuclear expression following PVN electrical stimula-
tion in anaesthetized rats. As shown in Figure 4A and 4C,
the c-Fos positive nuclei of PVN-activated cells in the spi-
nal cord were rare and systematically localized in the most
superficial layers of the dorsal horn (lamina I and outer
part of lamina II: I/IIo) as well as in the sympathetic inter-
medio-lateral column (not shown). Lamina I/IIo cells
immunopositive for c-Fos were mainly found in the ipsi-
lateral dorsal horn, with a slight preference for the medial
half of superficial laminae versus lateral half. This labeling
matched the distribution of OT-positive fibers and OT-
binding sites (see additional file 1). In good agreement,
OT-containing fibers (brown staining in Figure 4B, arrow-
heads) could be found close to the c-Fos positive nuclei
(blue staining in Figure 4B, arrows). PVN-activated cells
were identified as neurons because c-Fos-positive nuclei
were always surrounded by a thin (perinuclear) cytoplas-
mic compartment which was immunopositive for the
neuronal marker MAP2 and negative for the astroglial
marker GFAP (not shown). In a double immunofluores-
cence protocol against c-Fos and glutamic acid decarbox-
ylase (GAD), the enzyme synthesizing GABA, c-Fos
positive nuclei of PVN-activated cells were found in lami-
nae with poor GAD-immunoreactivity (I/IIo) while lam-
ina IIi showed a strong GAD-immunoreactivity (Figure
4C). Among 720 c-Fos positive nuclei observed in lumbar
segments of two animals (80% in lamina I, 20% in lamina
Table 1: Characteristics of synaptic events mediated by GABAA and AMPA receptors. 
Amplitude (pA) τR (ms) τD (ms) Frequency (Hz) n
GABAA-R mIPSCs 11.7 ± 0.8 3.17 ± 0.55 29.06 ± 3.83 0.13 ± 0.03 6
GABAA-R sIPSCs 11.1 ± 1.5 3.97 ± 0.72 30.35 ± 0.86 0.12 ± 0.02 6
AMPA-R mEPSCs -14.1 ± 0.9 1.27 ± 0.07 3.91 ± 0.17 0.81 ± 0.17 14
AMPA-R sEPSCs -16.3 ± 0.8 1.31 ± 0.10 4.23 ± 0.26 1.26 ± 0.47 16
Mean values and SEM are shown for amplitude, rise and decaying monoexponential time constants (τR and τD, respectively) and frequency of 
occurrence of spontaneous (sIPSCs and sEPSCs) and miniature (mIPSCs and mEPSCs) events. Note that the mean values were not statistically 
different while recorded in the absence (spontaneous) or in the presence of tetrodotoxin (miniatures).Page 4 of 12
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Differential effects of a selective oxytocin receptor (TGOT) on glutamatergic and GABAergic synaptic currentsFigu  2
Differential effects of a selective oxytocin receptor (TGOT) on glutamatergic and GABAergic synaptic cur-
rents. A: Raw recordings of spontaneous AMPA-R sEPSCs (left traces) illustrate the increase of frequency triggered by the 
application of TGOT (1 μM). This effect was reversible and observed in 35.7% of the lamina II neurons. Histograms on the right 
show the mean increase (± SEM) in frequency (with respect to control) of sEPSCs and mEPSCs. B: Elevation in the frequency 
of occurrence of GABAA-R sIPSCs was observed in all lamina II neurons recorded (n = 6 out of 6; raw traces and histogram on 
the left). However, TGOT never changed the frequency of miniature GABAA-R events (right histogram). Asterisks indicate 
statistical significance using Student's t-test, p < 0.05.
Molecular Pain 2008, 4:19 http://www.molecularpain.com/content/4/1/19IIo), none were found in GAD positive neurons (Figure
4D–F), thus suggesting that PVN-activated neurons repre-
sented a population of non-GABAergic, i.e. glutamatergic
neurons. In addition, we performed patch-clamp record-
ings of lamina II neurons in the current clamp mode to
characterize the effect of TGOT application on the mem-
brane potential at rest (i.e. no current injection: i = 0). As
illustrated in figure 5 (top trace), TGOT superfusion (1
μM) did not modify the membrane potential (control: -
63.6 ± 1.7 mV; TGOT: -60.8 ± 2.0 mV; n = 19; p > 0.05) in
the vast majority of the recorded lamina II neurons (n =
19 neurons out of 21; 90.5%). Only a small fraction of
neurons were depolarized transiently by TGOT (Figure 5,
bottom trace; n = 2 neurons out of 21; 9.5%), a result
Application of TGOT reveals a population of AMPA-R miniature EPSCs with slow activation and deactivation kineticsFigure 3
Application of TGOT reveals a population of AMPA-R miniature EPSCs with slow activation and deactivation 
kinetics. A: The histograms show the distribution of the decay time constants (τD) of miniature AMPA-R EPSCs pooled from 
6 cells and detected during an identical time period of 5 minutes before (top, n = 1075 events) and after the application of 1 μM 
TGOT (bottom, n = 1563 events). In the presence of TGOT, the appearance of slowly decaying mEPSCs was noted in addition 
to the fast mEPSC population of mEPSCs with faster kinetics also found in the control situation. B: Averaged currents obtained 
from 91 individual mEPSCs of representative recorded neurons during TGOT treatment. Compared to the fast mEPSCs 
(upper trace), the averages of slow mEPSCs obtained in the presence of TGOT (lower trace) exhibited longer monoexponen-
tial constants for rise time (from τR = 0.5 ms in control to τR = 0.8 ms in TGOT) and decaying phases (from τD = 4.5 ms in con-
trol to τD= 8.0 ms in OT). The mean amplitude was also reduced in the presence of TGOT. C: Graph summarizing the changes 
observed in the mean amplitude (Amp.), rise time (τR), and decay time constants (τD) of AMPA-R mEPSCs during perfusion of 
TGOT. TGOT-induced increase in frequency was always associated with the appearance of slow rising and decaying currents 
having lower amplitudes. All changes observed during TGOT application were significant: p < 0.01 (**: τR, n = 6), and p < 0.001 
(***: Amp and τD, n = 6) using the Student's t-test.Page 6 of 12
(page number not for citation purposes)
Molecular Pain 2008, 4:19 http://www.molecularpain.com/content/4/1/19which was in good agreement with the small number of c-
Fos positive lamina neurons II following PVN stimulation
in vivo. It should be noted that although TGOT was able
to increase the frequency of occurrence of sEPSPs (sponta-
neous excitatory postsynaptic potentials) in some
recorded neurons, these events did not reach an ampli-
tude or a frequency sufficient to trigger action potentials.
Discussion
In this study, we show that only a subpopulation of gluta-
matergic neurons (40–50%) possesses functional presyn-
aptic OT receptors which facilitate the synaptic release of
glutamate and ultimately excite a large population of
GABAergic interneurons, resulting in generalized increase
of synaptic inhibition in lamina II. This broad and mas-
sive facilitation of GABAergic inhibition is likely to repre-
sent the basis of the documented spinal antinociceptive
effect of OT and of PVN stimulation. This effect might
include a direct inhibition of superficial dorsal horn
interneurons, projection neurons and a selective reduc-
tion in Aδ/C fiber-mediated excitation of spinal cord dor-
sal horn neurons. We also give strong arguments on the
neurochemical nature of PVN-activated (OT-sensitive)
neurons in the superficial layers of the spinal cord. These
OT-activated neurons (seen as c-Fos positive) are mainly
localized in lamina I-II and were never GAD positive. This
is in good agreement with our electrophysiological result
showing that OT excites a specific population of glutama-
c-Fos expressing cells in the superficial layers of the dorsal horn after electrical stimulation of the ipsilateral PVNFigur  4
c-Fos expressing cells in the superficial layers of the dorsal horn after electrical stimulation of the ipsilateral 
PVN. A: Labeled c-Fos positive nuclei were localized in the most superficial layers i.e. lamina I and outer lamina II (IIo). B: 
Double immunoperoxidase labeling with an antibody against NpOT showed NpOT positive fibers (brown; arrowheads on 
inset) in the vicinity of c-Fos expressing nuclei (blue grey; arrows on inset). C: Double immunofluorescence labeling with an 
antibody against glutamic acid-decarboxylase (GAD) showed c-Fos positive nuclei (red cy3 fluorescence) in lamina I and IIo 
exhibiting a low GAD-immunoreactivity (green FITC fluorescence) whereas lamina IIi was strongly labeled by GAD antibody. 
D, E, F: In double immunofluorescence, c-Fos positive nuclei (arrowheads) never exhibited GAD labeled cytoplasm, despite 
the proximity in lamina IIo of GAD-immunoreactive neurons (arrows). A: 25 μm thick section; B: 1.5 μm semi-thin section; C-
F: 30 μm thick sections. Sale bars: 100 μm in A and C; 10 μm in B and D-F. Individual colour channels on merged images were 
adjusted in C-F.Page 7 of 12
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GABAergic interneurons in lamina II. This amplification
mechanism increasing the level of spinal GABAergic inhi-
bition is likely to explain most of the spinal OT antinoci-
ception seen in vivo.
Presynaptic effect of OT on glutamatergic lamina II 
neurons
As a first approach, we compared the effect of OT on spon-
taneous and miniature EPSCs/IPSCs. Whereas miniature
currents (i.e. recorded in the presence of TTX) reflect only
the activity of individual release sites, spontaneous synap-
tic currents allow action potentials and network activity-
driven neurotransmitter release. TGOT did not change the
frequency of occurrence of GABAA-R-mediated miniature
IPSCs (Figure 2B) but significantly increased AMPA-R-
mediated synaptic transmission in 50% of the recorded
lamina II neurons (Figure 2A). This suggested the pres-
ence of functional OT receptors on the presynaptic termi-
nals of a subpopulation of glutamatergic neurons and the
absence of such receptors on the synaptic endings of
GABAergic dorsal horn interneurons. Although c-Fos
expression was not observed in GAD positive neurons fol-
lowing PVN stimulation (Figure 4), we can not fully
exclude that OT receptors are expressed by GABAergic
interneurones. Should this be the case, we can however
conclude that their activation is certainly not sufficient to
directly increase the release probability of GABA (i.e. as
seen in miniature transmission experiments; Figure 2) or
to induce a significant action potential discharge in these
neurons (see Figure 5 and related results in the text). These
results are in agreement with those reported previously on
cultured laminae I-III dorsal horn neurons [25]. A major
difference observed in slices compared to dorsal horn pri-
mary cultures concerned the recruitment by OT of a pop-
ulation of AMPA-R mEPSCs with slow rise and decay
kinetics (Figure 3). These mEPSCs were rare under control
conditions (indicated by the histogram skewness in figure
3A) but were clearly seen after OT receptor stimulation.
Their slow kinetics might indicate that they originate at
synapses distant from the neuronal cell body, possibly on
distal dendrites. In culture, dorsal horn neurons possess
simpler dendritic trees and synapses normally impinging
on distal dendrites might be established on the cell body
and/or proximal dendrites. The existence of silent syn-
apses due to the absence of functional postsynaptic
AMPA-R has been previously shown in the spinal cord, in
normal and pathological situations [26,27]. Our results
indicate for the first time that a pool of "presynaptically
silent" synapses, which can be recruited or turned on
functionally by a neuromodulator such as OT (Figure 3),
might exist in the dorsal horn of the spinal cord. Although
we cannot completely exclude a postsynaptic locus for the
expression of this phenomenon [28,29], the fast onset
and reversibility TGOT effect on glutamatergic transmis-
sion argue rather in favor of the unmasking (i.e. by
increasing the release probability) of presynaptically
silent or whispering synapses at distal dendrites [29].
A subpopulation of OT-sensitive glutamatergic neurons 
recruits GABAergic interneurons in lamina II
In contrast with the effect on miniature IPSCs, OT recep-
tor activation induced a massive and generalized increase
in spontaneous GABAergic transmission, since it was
observed in all lamina II neurons from which we recorded
(Figure 2). This result is a key finding our study because it
allows us to postulate that OT sensitive neurons, which
are unlikely to be GABAergic (i.e. no effect of OT on the
frequency of GABAA mIPSCs), are functionally connected
(directly or indirectly) to all GABAergic interneurons in
lamina II and are responsible for the facilitation of GABA
release. Under the same conditions, however, the increase
in spontaneous AMPA-R-mediated EPSCs concerned only
a subpopulation of neurons (37%) comparable to that in
which OT-receptor activation increased the frequency of
mEPSCs. Our double immunofluorescence analysis indi-
cates that c-Fos expressing neurons after PVN stimulation
did not contain GAD, suggesting that the c-Fos positive
neurons were likely to be glutamatergic. An interesting
finding of the recent literature is the existence of a class of
interneurons displaying no action potential discharge
under resting conditions and receiving no apparent input
from peripheral sensory fibers even when the latter were
stimulated at C fiber strength [24]. These neurons are
excited by PVN stimulation and the time-course of their
Effect of TGOT on the membrane potential (Em) of lamina II neuronsFigure 5
Effect of TGOT on the membrane potential (Em) of 
lamina II neurons. Raw traces illustrating the effect of 
TGOT (1 μM, black arrowhead) on two different lamina II 
neurons. In the vast majority (90%) of lamina II neurons (top 
trace), TGOT application had no apparent effect on Em. In a 
small number of neurons (10%), TGOT induced a transient 
depolarization which reached the threshold value for the 
emission of action potentials (bottom trace).Page 8 of 12
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C afferent evoked electrical response. As indicated by the
results from our current clamp experiments (Figure 5), the
neurons directly depolarized by TGOT, represent a very
small population of lamina II neurons and this finding is
in good agreement with the c-Fos labeling seen in this
lamina after PVN stimulation. This result strongly sup-
ports the existence of an organized local spinal circuit
mediating the inhibitory effects of the descending hypoth-
alamic pathway at the spinal level. Immunohistochemical
Simplified diagram proposal summarizing the OT effects seen in lamina I-II at the light of our present studyFigure 6
Simplified diagram proposal summarizing the OT effects seen in lamina I-II at the light of our present study. 
Our results indicate that OT, which is physiologically released by hypothalamospinal fibers terminating in lamina I-II, activates a 
subpopulation of glutamatergic neurons (a) and, in particular, stimulates receptors present on presynaptic glutamatergic synap-
tic terminals (b). We also show that population of OT-sensitive glutamatergic neurons recruits the whole population of 
GABAergic neurons (c) resulting in an elevated GABAergic inhibitory tone in lamina II (represented as a green box). The dis-
section of the spinal action of OT can now unify previous observations which were in apparent contradiction. First, a network 
driven increase in GABAergic inhibition is likely to explain the specific inhibition of action potential triggered by the nociceptive 
activation of C and Aδ fibers [21,24]. In this case, a direct presynaptic inhibition of these fibers may be responsible for this 
effect (d). Alternatively, it remains possible that a specific C/Aδ network is inhibited through presynaptic fibre of neuronal inhi-
bition (d). It remains that neurons, receiving convergent sensory inputs are not the direct target for OT effect since only C/Aδ 
fibre activity is reduced (e). Second, our findings and mechanism proposal fully answer to the questions left open after the 
work of Robinson et al [18], i.e. the presynaptic inhibition of glutamate release after stimulation of the dorsal roots and the 
postsynaptic effect on Lamina I-II neurons (OT sensitive neurons). Abbreviations: E: excitatory glutamatergic neurons; I: inhibi-
tory GABAergic neurons.Page 9 of 12
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nuclei following PVN stimulation (Figure 4) were in line
with our electrophysiological results. Only a small
number of neurons was labeled after PVN stimulation and
these neurons were located in lamina I and in the outer
part of lamina II. It is interesting to note that this area is
the main target in the dorsal horn for OT-positive hypoth-
alamo-spinal fibers [8]. Recent work on rat or OT-knock-
out mice spinal cord has shown that OT reduced glutama-
tergic monosynaptic EPSCs evoked by electrical stimula-
tion of primary afferents in the superficial layers of
neonatal spinal cord slices [18]. These results are not con-
tradictory to our data since, as discussed in the work of
Robinson [18], the presynaptic effect on primary afferent
transmission might have been due to the activation of
GABAergic neurons exerting an inhibitory effect on synap-
tic glutamate release from primary afferents.
Taken together, our results are therefore consistent with
the hypothesis that the spinal excitation resulting from
peripheral C and Aδ sensory neurons is reduced by a local
network involving a subpopulation of glutamatergic neu-
ron activated by OT which excites GABAergic interneu-
rons in lamina II (Figure 6). This synaptic organization
might also explain earlier observations made in vivo and
showing that application of OT induced either excitation
or inhibition of dorsal horn neurons [23].
Conclusion
In conclusion, we show that a descending hypothalamos-
pinal control using OT as neurotransmitter exerts its
effects via a specific local neuronal network in lamina II.
This network involves a subpopulation of OT receptor-
expressing glutamatergic neurons that distribute their
excitation to all GABAergic neurons in lamina II in order
to limit or block nociceptive afferent messages originating
from C and Aδ primary afferents [21]. These PVN- and
OT-activated lamina II interneurons certainly represent an
interesting target for the development of specific thera-
peutic strategies to reduce nociceptive sensory messages at
the spinal level.
Methods
All experiments were conducted in accordance with the
recommendations of the International Association for the
Study of Pain and directives set by the European Commu-
nity Council Directive (86/69/EEC of November 24,
1986) and authorization from the French Department of
Agriculture (License no. 67–116 to PP).
Spinal cord slice preparation
In this study we used 15- to 30-day-old Wistar rats anes-
thetized with a single i.p injection of ketamine (150 mg/
kg). A detailed description of the dissection procedure can
be found elsewhere [30,31]. Briefly, the spinal cord was
removed by hydraulic extrusion and placed into ice-cold
sucrose artificial cerebrospinal fluid (s-ACSF) containing
(in mM): 248 sucrose, 11 glucose, 23 NaHCO3, 2 KCl,
1.25 KH2PO4, 2 CaCl2, and 1.3 MgSO4 and was continu-
ously bubbled with 95% O2-5% CO2. Transverse slices
(600 μm thick) were cut from the lumbar segment of the
spinal cord using a vibratome and stored at room temper-
ature in an incubation chamber filled with oxygenated
(95% O2-5% CO2) regular ACSF containing (in mM) 126
NaCl, 26 NaHCO3, 1.25 NaH2PO4, 2.5 KCl, 2 CaCl2, 2
MgCl2, and 10 Glucose. Spinal cord slices were stored for
at least 1 hour before being placed into the recording
chamber. The slices were continuously superfused with
oxygenated ACSF at a flow rate of approximately 3 ml per
minute.
Patch clamp recordings, data acquisition, and analysis
All electrophysiological experiments were performed at
room temperature. Lamina II neurons were recorded
blindly using the whole-cell configuration of the patch-
clamp technique and systematically dialyzed with biocy-
tin in order to localize and determine the morphological
characteristics of the recorded interneurons. Synaptic cur-
rents were recorded under voltage-clamp using an Axo-
patch 200B amplifier. The patch pipettes were filled with
a solution containing (in mM): 80 Cs2SO4, 8 CsCl, 2
MgCl2, 10 HEPES, 10 Biocytin, and adjusted to pH 7.3
with CsOH. In voltage-clamp mode, lamina II neurons
were held at potentials of -60 mV and 0 mV to record
glutamatergic and GABAergic synaptic currents, respec-
tively. In a subset of experiments, we have used the current
clamp mode to measure changes in the membrane poten-
tial (Em). Em was initially adjusted at -60 mV (i.e. with a
small current injection if necessary), a value often corre-
sponding to the resting membrane potential in our condi-
tion (no current injection: i = 0). For these experiments,
cesium was replaced by potassium in the pipette solution
described above. Synaptic currents were detected and ana-
lyzed individually using the WinEDR and WinWCP soft-
wares (courtesy Dr J. Dempster, University of Strathclyde,
Glasgow, UK) to extract their frequency of occurrence,
amplitude, monoexponential rise time (τR), and decay
time constants (τD). Results are expressed as mean value ±
S.E.M. Statistical analysis was performed using parametric
one-way ANOVA with Student's t-tests to compare means;
sets of data were considered as different when p < 0.05.
Immunocytochemistry following in vivo stimulation of PVN
In anesthetized rats (alpha-chloralose 2% and urethane
20%) a bipolar electrode was implanted in the left par-
aventricular nucleus to perform 90 minutes stimulation
(1 msec, 100 nA, 20 Hz). Immediately after the stimula-
tion, tissues were fixed by an intracardiac perfusion of
paraformaldehyde 4%. After a few hours of post fixation
in the same fixative, spinal cords were removed, embed-Page 10 of 12
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30 μm thick sections for direct observations or in 40 μm
thick sections for preparation of semithin (1.5 μm) sec-
tions. Detailed procedures and antibodies used are indi-
cated in additional file 1.
Drug application and perfusion solution
To activate oxytocin receptors, we used the selective ago-
nist [Thr4, Gly7]-oxytocin (TGOT; Bachem, Germany)
[32]. OT receptors were selectively inhibited with
d(CH2)5- [Tyr(Me)2, Thr4-Tyr-NH29] ornithine vasotocin
[33], a selective OT receptor antagonist (OTA; Sigma).
Glutamate-receptor-mediated synaptic transmission was
recorded in the continuous presence of the GABAA-recep-
tor antagonist bicuculline (BIC: bicuculline methiodide)
and of the glycine-receptor antagonist strychnine (strych-
nine hydrochloride; Sigma). GABAergic synaptic currents
were isolated in the presence of the general ionotropic
glutamate receptor blocker kynurenic acid (2 mM) and of
strychnine (1 μM) to block glycine receptors. To record
miniature synaptic transmission, tetrodotoxin (0.5 μM)
was present in the bath perfusion at a steady-state.
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